Document:

EX-4.2

 EXHIBIT 4.2 
 REGISTRATION RIGHTS AGREEMENT 
 This REGISTRATION RIGHTS AGREEMENT (this
“Agreement”), is made and entered into as of June 4, 2012, between Sunstone Hotel Investors, Inc., a Maryland corporation (the “Company”) and BRE/CS Holdings LLC, a Delaware limited liability company (together
with its successors and assigns, the “Investor”). 
 WHEREAS, the Company, Sunstone Saint Clair, LLC, a
Delaware limited liability company, and Patriot Mortgage Borrower L.L.C., a Delaware limited liability company and a wholly owned subsidiary of Investor (“Patriot”), have entered into the Real Estate Purchase Agreement, dated as of
April 20, 2012 (the “Purchase Agreement”), pursuant to which the Company agreed, among other things, to issue 5,454,164 shares of its common stock, par value $0.01 per share (the “Common Stock”), to the
Patriot; 
 WHEREAS, Patriot has designated Investor to receive the Common Stock; and 

WHEREAS, the Company desires to provide the Investor with certain registration rights with respect to the Common Stock to be issued to
the Investor pursuant to the Purchase Agreement. 
 NOW, THEREFORE, in consideration of the foregoing, the parties hereto agree
as follows: 
  

	1.	DEFINITIONS. 

 As used in this
Agreement, the following terms shall have the following respective meanings: 
 “Affiliate”: with regard to a
Person, a Person that controls, is controlled by, or is under common control with, such original Person. For purposes of this definition, “control” when used with respect to any Person means the power to direct the management and policies
of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “affiliated,” “controlling” and “controlled” have meanings correlative to the
foregoing. 
 “Closing Date”: as defined in the Purchase Agreement. 

“Commission”: the Securities and Exchange Commission or any other applicable Federal agency at the time administering
the Securities Act. 
 “Company”: as defined in the preamble, and shall include, where the context requires any
Person into which the Company is merged or with which the Company is consolidated. 
 “Demand Registration”: an
effective registration pursuant to a request made by the Investor pursuant to Section 2.1; provided, however, that a registration shall not count as a Demand Registration unless the Investor is able to register all of the Shares
requested to be included in such registration. 

 “Exchange Act”: the Securities Exchange Act of 1934, as amended.

 “Overhang Risk”: a substantial risk that the sale of some or all of the Shares sought to be sold will
substantially reduce the proceeds or price per Share to be derived from the sale. 
 “Person”: an individual,
partnership, corporation, company (including a limited liability company), trust or unincorporated organization, or a government or agency or political subdivision thereof. 
 “Resale Rules”: as defined in Section 3.3. 

“Securities Act”: the Securities Act of 1933, as amended. 

“Shares”: the shares of Common Stock issued to the Investor pursuant to the Purchase Agreement, and any other securities
that subsequently may be issued or issuable by the Company pursuant to the Purchase Agreement or as a result of a stock split or dividend or other similar transaction involving the Shares and any securities into which the Shares may thereafter be
changed or exchanged as a result of the reincorporation of the Company or merger, consolidation, recapitalization or other similar transaction. 
 “Shelf Registration”: an effective registration under Rule 415 of the Securities Act pursuant to Section 4.9 of the Purchase Agreement. 

“Violation”: as defined in Section 3.2(a). 

 

	2.	REGISTRATION RIGHTS. 

 2.1
Demand Registration. During the period from and after the Closing Date, if the Company is not eligible to file a registration statement to register the resale of the Investor’s shares pursuant to Rule 415 under the Securities Act or has
not maintained the effectiveness of the shelf registration statement pursuant to Section 2.2 of this Agreement, the Investor may request the Company to file a registration statement to register the resale of some or all of the Investor’s
Shares, which registration statement will contemplate the ability of the Investor to do an underwritten offering. The Investor shall be entitled to one Demand Registration. The Company’s obligations in this Section 2.1 are subject to
Section 2.3. 
 2.2 Shelf Registration. From and after the declaration of effectiveness of the Shelf Registration,
the Company shall use reasonable best efforts to cause the Shelf Registration to be continuously effective so long as there are any Shares outstanding. In connection with the Shelf Registration, the Company will, as promptly as reasonably
practicable upon notice from the Investor requesting a shelf take-down, cooperate in any such shelf take-down by amending or supplementing the prospectus related to such registration as may be reasonably requested by the Investor or as may be
otherwise required to effect the sale of the Shares to be sold thereunder. The Investor shall give the Company prompt written notice of the consummation of a sale effected in any shelf take-down. The Company’s obligation to maintain the
effectiveness of the Shelf Registration shall terminate at such time as the Investor’s Shares are freely tradeable pursuant to the Resale Rules without limitations (including any limitation on volume or manner of sale). The Company’s
obligations in this Section 2.2 are subject to Section 2.3. 

  
 2 

 2.3 Company’s Ability to Postpone. The Company shall have the right to postpone
the filing or effectiveness of a registration statement under Section 2.1 and each proposed sale of Shares by the Investor under an effective registration statement under Section 2.1 or 2.2, for a reasonable period of time (not exceeding
60 days) (the “Blackout Period”) if the Company furnishes the Investor with a certificate signed by the Chief Executive Officer of the Company stating that the Company’s board of directors, in its good faith judgment, has
determined that effecting the registration or sale at such time would adversely affect a material financing, acquisition, disposition of assets or stock, merger or other comparable transaction or would require the Company to make public disclosure
of information the public disclosure of which would have a material adverse effect upon the Company; provided, that the Blackout Period shall terminate if effecting the registration or sale would cease to adversely affect any such transaction
(whether because such transaction shall have been disclosed, abandoned or otherwise), or if the applicable information has been disclosed or if the disclosure of such information would cease to have a material adverse effect upon the Company, as the
case may be, and the Company shall provide the Investor with prompt notice of the termination of the Blackout Period; provided, further, however, that notwithstanding anything herein to the contrary, the Company shall only be
entitled to exercise its rights under this Section on one occasion during any 9-month period; provided further, however, that during any such Blackout Period, the Company shall also delay the filing or effectiveness of, and
shall not sell or permit a sale under, any registration statement with respect to any securities of the Company to be sold by the Company or by any other stockholders of the Company. 

2.4 Registration Procedures. If and whenever the Company is required by any of the provisions of this Article 2 to effect the
registration of any of the Shares under the Securities Act, the Company shall use its best efforts to effect the registration and the sale of such Shares in accordance with the intended method of disposition thereof, and pursuant thereto the Company
shall as expeditiously as possible: 
 (a) prepare and, in the case of a Demand Registration, no later than 45
days after a request for a Demand Registration, file with the Commission a registration statement with respect to such Shares and use its reasonable efforts to cause such registration statement to become effective as promptly as practicable, and
remain effective for as long as shall be necessary to complete the distribution of the Shares so registered; provided, that before filing a registration statement or prospectus or any amendments or supplements thereto, the Company shall
furnish to the counsel selected by the Investor copies of all such documents proposed to be filed, to the extent specifically requested by such counsel, including documents that are to be incorporated by reference into the registration statement,
amendment or supplement, which documents shall be subject to the review and reasonable comment of such counsel; 

(b) notify the Investor when a registration statement or any amendment thereto has been filed and when it has become
effective; 
 (c) prepare and file with the Commission such amendments and supplements to such registration
statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective and to comply with the provisions of the Securities Act with respect to the sale or other disposition of all Shares covered
by such registration statement; 

  
 3 

 (d) furnish to the Investor such numbers of copies of the registration
statement, each amendment or supplement thereto, a summary prospectus or other prospectus, including a preliminary prospectus or any amendment or supplement to any prospectus, in conformity with the requirements of the Securities Act, and such other
documents, as the Investor may reasonably request, in order to facilitate the public sale or other disposition of the Shares covered by such registration statement (it being understood that the Company consents to the use of such prospectus and any
amendment or supplement thereto by the Investor and the underwriters, if any, in connection with the offering and sale of the Shares thereby); 
 (e) use its reasonable efforts to (i) register and qualify the Shares covered by such registration statement under such other securities or blue sky laws of such jurisdictions as the Investor shall
reasonably request, (ii) keep such registration or qualification in effect for so long as such registration statement remains in effect, (iii) cooperate with the Investor and the underwriters, if any, and their respective counsel in
connection with any filings required to be made with the Financial Industry Regulatory Authority and (iv) do any and all other acts and things reasonably requested by the Investor to assist it to consummate the public sale or other disposition
in such jurisdictions of the Shares owned by the Investor, except that the Company shall not for any such purpose be required to qualify to do business as a foreign corporation in any jurisdiction wherein it is not so qualified or to file therein
any general consent to service of process; 
 (f) otherwise use its reasonable efforts to comply with all
applicable rules and regulations of the Commission, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve months, beginning with the first fiscal quarter beginning
after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act; 
 (g) use its reasonable efforts to list and thereafter to maintain the listing of such Shares covered by such registration statement on any securities exchange or interdealer quotation system on which the
shares of Common Stock of the Company are then listed, if the listing or quotation of such Shares is then permitted under the rules of such exchange or interdealer quotation system; 

(h) if the Investor intends to dispose of its Shares through an underwritten public offering, enter into and perform its
obligations under an underwriting agreement, in customary and usual form, with the managing underwriter of such underwritten offering, including, without limitation, to obtain an opinion of counsel to the Company and a “comfort letter”
from the independent public accountants to the Company in the usual and customary form for such underwritten offering; 

  
 4 

 (i) promptly notify the Investor of the happening of any event of which it
has knowledge as a result of which the prospectus included in the registration statement, as then in effect, contains an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then existing, and, at the request of the Investor (subject to the Company’s ability to postpone such filing pursuant to Section 2.3 hereof), the Company shall promptly
prepare, file and furnish to the Investor a supplement or amendment to the prospectus so that, as thereafter delivered to the purchasers of such Shares, such prospectus shall not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; provided, that the Investor shall refrain from selling any Shares until such supplement or
amendment to the prospectus has been filed; 
 (j) make every reasonable effort to prevent the entry of any order
suspending the effectiveness of the registration statement and, in the event of the issuance of any such stop order, or of any order suspending or preventing the use of any related prospectus or suspending the qualification of any security included
in such registration statement for sale in any jurisdiction, the Company shall promptly notify the Investor and use its best efforts to obtain the prompt withdrawal of such order; 

(k) make the Company’s executive officers available for presentations to investors to discuss the affairs of the
Company at times that may be mutually and reasonably agreed upon (including, without limitation, to the extent customary, senior management attendance at due diligence meetings with the underwriters and their counsel and road shows); and provide the
Investor, the underwriter and their respective counsel and accountants such access to its books and records, all as shall be necessary to conduct a reasonable investigation within the meaning of the Securities Act; 

(l) deliver promptly to Investor’s counsel copies of all correspondence between the Commission and the Company, its
counsel or auditors and all memoranda relating to discussions with the Commission or its staff with respect to such registration statement; and 
 (m) upon the request of the Investor, take any and all other actions which may be reasonably necessary to complete the registration and thereafter to complete the distribution of the Shares so registered.

 2.5 Underwritten Offering. 
 (a) If the proposed sale by the Investor in a Demand Registration or Shelf Registration is an underwritten offering, the Investor shall (together with the Company as provided in Section 2.4(h)),
enter into an underwriting agreement in customary and usual form with the managing underwriter selected for such underwriting by the Investor. For the avoidance of doubt, the Investor shall not be required, without its approval, to enter into any
underwriting agreement contemplated by this Agreement that does not contain terms acceptable to it in its discretion. The Investor hereby agrees that it may not participate in any underwritten offering

  
 5 

 
hereunder unless it (i) agrees to sell its Shares on the basis provided in the underwriting agreement and (ii) completes and executes all questionnaires, powers of attorney and other
documents reasonably required under the terms of the underwriting agreement or by the Company. 
 (b) The Investor may not make
more than one underwritten offering whether pursuant to a Demand Registration or Shelf Registration. For this purpose, “underwritten offerings” do not include block purchases from the Investor by brokers or dealers without any marketing
efforts by the Company or the Investor. 
  

	3.	PROVISIONS APPLICABLE TO REGISTRATION RIGHTS. 

 3.1 Expenses. 
 All expenses incurred in any Shelf Registration or Demand
Registration (or any attempted Shelf Registration or Demand Registration that is not consummated) shall be paid by the Company, including, without limitation, (i) the fees and expenses of its counsel, and fees and expenses related to the
preparation, printing and distribution of the registration statement and the prospectus used in connection therewith and any amendment or supplement thereto, (ii) any necessary accounting expenses, including any special audits which shall be
necessary to comply with governmental requirements in connection with any such registration, including the expense related to any comfort letters and (iii) all registration and filing fees, listing fees and all fees and expenses of complying
with the securities or blue sky laws of any jurisdictions; provided, that the Company shall not bear any underwriter’s discounts or commissions or fees or fees of placement agents or fees and disbursements of counsel for the Investor.

 3.2 Indemnification. In the event the Investor’s Shares are included in a registration statement under Article 2:

 (a) Indemnity by Company. Without limitation of any other indemnity provided to the Investor, to the
extent permitted by law, the Company will indemnify and hold harmless the Investor, the Affiliates, officers, directors and partners or members of the Investor, each underwriter (as defined in the Securities Act), and each Person, if any, who
controls (within the meaning of the Securities Act) the Investor or an underwriter, against any losses, claims, damages, liabilities and expenses (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other
federal or state law, insofar as such losses, claims, damages, liabilities and expenses (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in or incorporated by reference in such registration statements (including any preliminary prospectus, summary prospectus or final
prospectus contained therein or any amendments or supplements thereto), (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, or (iii) any other violation or alleged violation by the Company, its officers, employees or agents of this Agreement, the Securities Act, the Exchange Act, any state securities law or
any rule or regulation promulgated under the 

  
 6 

 
Securities Act, the Exchange Act or any state securities law, and the Company will reimburse the Investor and its Affiliates, officers, directors, partners or members, underwriter and controlling
Person on demand for any reasonable legal or other expenses incurred by them in connection with investigating or defending any such loss, claim, damage, liability, expense or action; provided, however, that the Company shall not be
liable to the Investor in any such case for any such loss, claim, damage, liability, expense or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information
furnished expressly for use in connection with such registration by the Investor or any Affiliate, officer, director, partner, member or controlling Person thereof as provided in section 3.2(b) below; 

(b) Indemnity by the Investor. In connection with any registration statement in which the Investor is
participating, the Investor will furnish to the Company in writing such reasonably necessary information as the Company reasonably requests for use in connection with any such registration statement or prospectus and, to the extent permitted by law,
will indemnify the Company, its directors and officers and each Person who controls (within the meaning of the Securities Act) the Company against any losses, claims, damages, liabilities and expenses resulting from any Violation, but only to the
extent that such Violation is contained in any information furnished in writing to the Company by the Investor stated to be specifically for use in such registration statement or prospectus (the furnishing of such reasonably necessary information by
the Investor being a condition precedent to the Company’s obligation to cause the registration statement to become effective); provided, that the obligation to indemnify will be several and not joint with any other Person and will be
limited to the net amount received by the Investor from the sale of Shares pursuant to such registration statement;. 
 (c) Notice; Right to Defend. Promptly after receipt by an indemnified party under this Section 3.2 of notice of the commencement of any action (including any governmental action), such
indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 3.2, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the
right to participate in, and, if the indemnifying party agrees in writing that it will be responsible for any costs, expenses, judgments, damages and losses incurred by the indemnified party with respect to such claim, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and
expenses to be paid by the indemnifying party, if the indemnified party reasonably believes that representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall
relieve such indemnifying party of any liability to the indemnified party under this Section 3.2 only if and to the extent that such failure is prejudicial to its ability to defend such action, and the omission so to deliver written notice to
the indemnifying party will not relieve it of any liability that it may have to any indemnified party other than under this Section 3.2. Consent of the indemnified party shall be required for the entry of any

  
 7 

 
judgment or to enter into a settlement if such judgment or settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a
release from all liability in respect of such claim or litigation; 
 (d) Contribution. If the
indemnification provided for in this Section 3.2 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying
party, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect
the relative fault of the indemnifying party on the one hand and of the indemnified party on the other hand in connection with the statements or omissions which resulted in such loss, liability, claim, damage or expense as well as any other relevant
equitable considerations. The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a
material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
Notwithstanding the foregoing, the amount an Investor shall be obligated to contribute pursuant to this Section 3.2(d) shall be limited to an amount equal to the proceeds to the Investor of the Shares sold pursuant to the registration statement
which gives rise to such obligation to contribute (less the aggregate amount of any damages which the Investor has otherwise been required to pay in respect of such loss, claim, damage, liability or action or any substantially similar loss, claim,
damage, liability or action arising from the sale of such Shares). No Person guilty of fraudulent misrepresentation (within the meaning of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. In addition, no Person shall be obligated to contribute hereunder any amounts in payment for any settlement of any action or claim, effected without such Person’s written consent, which consent shall not be unreasonably
withheld; and 
 (e) Survival of Indemnity. The indemnification provided by this Section 3.2 shall be
a continuing right to indemnification and shall survive the registration and sale of any securities by any Person entitled to indemnification hereunder and the expiration or termination of this Agreement. 

3.3 Rule 144. In order to permit the Investor to sell the Shares it holds, if it so desires, from time to time pursuant to Rule
144 under the Securities Act promulgated by the Commission or any successor to such rule or any other rule or regulation of the Commission that may at any time permit the Investor to sell its Shares to the public without registration
(“Resale Rules”), the Company will: 
 (a) comply with all rules and regulations of the
Commission applicable in connection with use of the Resale Rules; 
 (b) make and keep adequate and current
public information available, as those terms are understood and defined in the Resale Rules, at all times; 

  
 8 

 (c) file with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act; 
 (d) furnish to the Investor
so long as it owns any Shares, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of the Resale Rules, the Securities Act and the Exchange Act, (ii) a copy of the most recent
annual or quarterly report of the Company and any other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing an Investor of any rule or regulation of the Commission which
permits the selling of any such Shares without registration; and 
 (e) take any action (including cooperating
with the Investor to cause the transfer agent to remove any restrictive legend on certificates evidencing the Shares) as shall be reasonably requested by the Investor or which shall otherwise facilitate the sale of Shares from time to time by the
Investor pursuant to the Resale Rules. 
 3.4 Investor Status and Responsibilities. The Investor acknowledges the
limitations that may be imposed upon the Investor under Section 10 of the Exchange Act and the rules and regulations thereunder in connection with the Investor’s sale or transfer of Shares and agrees to sell or transfer any such Shares
only subject to any such applicable limitations. 
  

	4.	MISCELLANEOUS. 

 4.1
Amendment; Termination. This Agreement may be amended, modified or supplemented but only in writing signed by each of the parties hereto. This Agreement shall terminate when the Investor no longer owns any Shares. 

4.2 Notices. Any notice, request, instruction or other document to be given hereunder by a party hereto shall be in writing,
personally delivered or mailed by first-class registered or certified mail, return receipt requested, postage prepaid or delivered by Federal Express or another nationally recognized overnight commercial courier against receipt, or sent by facsimile
or electronic mail providing that a confirming copy is simultaneously sent by Federal Express or other nationally recognized overnight commercial courier: 
 If to the Company, addressed as follows: 
 Sunstone Hotel Investors, Inc.

 120 Vantis, Suite 350 
 Aliso Viejo, California 92656 
 Attention: Legal Department 

Telephone No.: (949) 382-3005 
 Facsimile No.: (949) 382-4060 
 Email: dsloan@sunstonehotels.com;
jkessler@sunstonehotels.com 
 with a copy to: 
 Sunstone Hotel Investors, Inc. 
 120 Vantis, Suite 350 

Aliso Viejo, California 92656 

  
 9 

 Attention: Finance Department 

Telephone No.: (949) 382-3082 
 Facsimile No.: (949) 382-4060 
 Email: bgiglia@sunstonehotels.com;
jarabia@sunstonehotels.com 
 and with a copy to: 

Ginsberg Jacobs LLC 
 300 South Wacker Drive, Suite 2450 
 Chicago, Illinois 60606 

Attention: Steven F. Ginsberg and Ana L. Acena 
 Telephone No.: (312) 660-9614 and (312) 660-9618 
 Facsimile No.:
(312) 660-9612 
 E-mail: sginsberg@ginsbergjacobs.com; aacena@ginsbergjacobs.com 

If to the Investor, addressed as follows: 
 BRE/CS Holdings LLC 
 c/o Blackstone Real Estate Partners VI, L.P. 

345 Park Avenue 

New York, New York 10154 
 Attention: Tyler Henritze 
 Facsimile No.: 646-253-8712 

E-mail: henritze@blackstone.com 
 with a copy to: 
 Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York, New York 10017 
 Attention: Erik Quarfordt and Brian Stadler 

Telephone No: (212) 455-2000 
 Facsimile No.: (212) 455-2502 
 Email: equartfordt@stblaw.com;
bstadler@stblaw.com 
 or to such other individual or address as a party hereto may designate for itself by notice given as herein
provided. Such notice shall be deemed given on the date of receipt by the addressee or the date receipt would have been effectuated if delivery were not refused. The inability to deliver a notice because of a changed address of which proper notice
was not given shall be deemed a refusal of such notice. 
 4.3 Waivers. The failure of a party hereto at any time or
times to require performance of any provision hereof shall in no manner affect its right at a later time to enforce the same. No waiver by a party of any condition or of any breach of any term, covenant, representation or warranty contained in this
Agreement shall be effective unless in writing, and no waiver in any one or more instances shall be deemed to be a further or continuing waiver of any such condition or breach in other instances or a waiver of any other condition or breach of any
other term, covenant, representation or warranty. 

  
 10 

 4.4 Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 4.5
Interpretation. The headings preceding the text of Articles and Sections included in this Agreement are for convenience only and shall not be deemed part of this Agreement or be given any effect in interpreting this Agreement. The use of the
masculine, feminine or neuter gender herein shall not limit any provision of this Agreement. The use of the terms “including” or “include” shall in all cases herein mean “including, without limitation” or “include,
without limitation,” respectively. References to Articles, Sections or Subsections shall refer to those portions of this Agreement. 
 4.6 Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO ITS CONFLICTS OF LAWS PRINCIPLES. 

4.7 Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors and assigns. At the election of the Investor, upon notice to the Company, in the event that any transferee of the Investor shall acquire Shares in any manner, whether by gift, bequest, purchase, operation of law or otherwise, such
transferee shall, without any further writing or action of any kind, be entitled to receive the benefits of and, if applicable, be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement.

 4.8 Severability. If any provision of this Agreement shall be held invalid, illegal or unenforceable, the validity,
legality or enforceability of the other provisions hereof shall not be affected thereby, and there shall be deemed substituted for the provision at issue a valid, legal and enforceable provision as similar as possible to the provision at issue.

 4.9 Entire Understanding. This Agreement sets forth the entire agreement and understanding of the parties hereto with
respect to the matters set forth herein and supersedes any and all prior agreements, arrangements and understandings among the parties. 
 4.10 Specific Performance. Each of the parties acknowledges that the obligations undertaken by it pursuant to this Agreement are unique and that the other parties will not have an adequate remedy
at law if it shall fail to perform any of its obligations hereunder, and each party therefore confirms that the right of each other party hereto to specific performance of the terms of this Agreement is essential to protect the rights and interests
of such parties. Accordingly, in addition to any other remedies that the parties may have at law or in equity, each party shall have the right to have all obligations, covenants, agreements and other provisions of this Agreement specifically
performed by each other party, and shall have the right to obtain preliminary and permanent injunctive relief to secure specific performance and to prevent a breach or contemplated breach of this Agreement by each other party. 

  
 11 

 4.11 Recapitalizations; Reorganization. In the event that any Shares or other
securities are issued in respect of, in exchange for, or in substitution of the Shares by reason of any reorganization, recapitalization, reclassification, merger, consolidation, spin-off, partial or complete liquidation, share dividend, split-up,
sale of assets, distribution to stockholders or combination of the Shares or any other similar change in the Company’s capital structure, the Company agrees that appropriate adjustments shall be made to this Agreement to ensure that the
Investor has, immediately after consummation of such transaction, substantially the same rights in respect of the Company or another issuer of securities, as applicable, as it has immediately prior to consummation of such transaction in respect of
the Company under this Agreement. 
 * * * * * 

  
 12 

 IN WITNESS WHEREOF, the undersigned has executed this Agreement as of the date and year
first above written. 
  

			
	SUNSTONE HOTEL INVESTORS, INC.
		
	By:	 	 /s/ Kenneth E. Cruse

		 	Name: Kenneth E. Cruse
		 	Title: President and Chief Executive Officer
	
	BRE/CS HOLDINGS LLC
		
	By:	 	 /s/ Glenn Alba

		 	Name: Glenn Alba
		 	Title: Managing Director

 [Signature Page to Registration Rights Agreement] 

  
 13Form of Warrant to Purchase Common Stock

 Exhibit 4.1 
 QUICKLOGIC CORPORATION 
 WARRANT TO PURCHASE COMMON STOCK 

Warrant No.: [            ] 
 Number of Shares of Common Stock: 
 Date of Issuance:
                    , 2012 (“Issuance Date”) 
 Quicklogic Corporation, a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
[            ], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at
the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at
any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below),
[            ] ([            ]) fully paid nonassessable shares of Common Stock (as defined below) (the “Warrant
Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 15. This Warrant is one the Warrants to purchase Common Stock (the “Warrants”) issued
pursuant to (i) Section 4 of that certain Underwriting Agreement, dated as of [            ], 2012 by and between the Company and Roth Capital Partners, LLC (the
“Underwriting Agreement”) and (ii) the Company’s Registration Statement on Form S-3 (File number 333-161501) (the “Registration Statement”). 

1. EXERCISE OF WARRANT. 
 (a) Mechanics of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after the Exercisability Date, in whole or in part, by delivery
of (i) a properly completed and executed written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant and (ii) (A) payment to the
Company of an amount equal to the applicable Exercise Price (as defined below) multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of
immediately available funds or (B) if the conditions for Cashless Exercise (as defined below) set forth in Section 1(d) are satisfied, by notifying the Company, through delivery of the Exercise Notice, that this Warrant is being exercised
pursuant to a Cashless Exercise. The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have
the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. On or before the second (2nd) Business Day following the date on which the Company
has received each of the Exercise Notice and the Aggregate Exercise Price (or a duly executed and delivered notice of Cashless Exercise), the Company shall transmit by facsimile an acknowledgment of confirmation of receipt of the Exercise Notice to
the Holder and American Stock Transfer & Trust Company, the Company’s transfer Agent (“Transfer Agent”). On or before the third (3rd) Business 

 
Day following the date on which the Company has received the Exercise Notice (the “Share Delivery Date”), the Company shall (X) provided that the Transfer Agent is
participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program, upon the request of the Holder, credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue
and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Notice and the payment of the Aggregate Exercise Price (or a duly executed and delivered notice of Cashless Exercise), the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates
evidencing such Warrant Shares, as the case may be. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for exercise is greater
than the number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event later than five (5) Business Days after any exercise and at its own expense, issue a new Warrant (in accordance
with Section 7(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No
fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded down to the nearest whole number. The Company shall pay any and all taxes (other than
taxes based upon the income of the Holder) which may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant; provided that the Company shall not be required to pay any tax that may be payable in
respect of any transfer involved in the issue and delivery of shares of Common Stock in any name other than that of the Holder, in either case with respect to any income or transfer tax due by the Holder with respect to such shares of Common Stock
issued upon exercise of this Warrant. 
 (b) Exercise Price. For purposes of this Warrant, “Exercise
Price” means $[            ], subject to adjustment as provided herein. 
 (c) Company’s Failure to Timely Deliver Securities. If the Company shall fail for any reason or for no reason to issue to the Holder within three (3) Business Days of receipt of the
Exercise Notice in compliance with the terms of this Section 1, a certificate for the number of shares of Common Stock to which the Holder is entitled and register such shares of Common Stock on the Company’s share register or to
credit the Holder’s balance account with DTC for such number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise of this Warrant, and if on or after such Trading Day the Holder purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such exercise that the Holder anticipated receiving from the Company (a “Buy-In”), then the
Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver such certificate 

  
 -2-

 
(and to issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Warrant Shares and pay cash
to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock, times (B) the Closing Bid Price on the date of exercise. 

(d) Payment of Exercise Price. The Company shall promptly, and in no case later than the second (2nd) Business Day immediately following such receipt, confirm
receipt of an Exercise Notice via facsimile to the number specified in such Exercise Notice. The Holder shall pay the Exercise Price to the Company in immediately available funds upon receipt of such confirmation by the Company; provided,
however, that if at any time on or after the Exercisability Date the Registration Statement covering the issuance of the Warrant Shares upon exercise of such Warrants is not effective on such exercise date or the prospectus contained in such
Registration Statement is not available for use with respect to the issuance of the Warrant Shares to the Holder, the Holder may, at its election, satisfy its obligation to pay the Exercise Price through a “Cashless Exercise,” in which
event the Company shall issue to the Holder the number of Warrant Shares determined as follows: 
  

					
		 		  	X = Y [(A-B)/A]
			
		 	where:        	  	
			
		 		  	X = the number of Warrant Shares to be issued to the Holder.
			
		 		  	Y = the number of Warrant Shares with respect to which this Warrant is being exercised.
			
		 		  	A = the Weighted Average Price on the Trading Day immediately prior to (but not including) the date on which the Company receives a duly executed and delivered notice of Cashless
Exercise.
			
		 		  	B = the Exercise Price.

 (e) Rule 144. For purposes of Rule 144(d) promulgated under the Securities Act, as in
effect on the date hereof, it is intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this
Warrant was originally issued to the Holder. 
 (f) Disputes. In the case of a dispute as to the determination of the
Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed. 
 (g) Beneficial Ownership. The Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s
affiliates) would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate
number of shares of Common Stock beneficially owned by such Person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made,
but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and

  
 -3-

 
(ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without
limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this
paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder
may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission,
as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding shares of
Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that (i) any such
increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder. 

(h) Principal Market Regulation. At all times, irrespective of whether the Company is listed on the Principal Market, the Company
shall not be obligated to issue any shares of Common Stock upon exercise of this Warrant if the issuance of such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the Company may issue upon conversion or
exercise or otherwise of all Warrants without breaching the rules or regulations of the Principal Market as if the Company were regulated by such rules or regulations (the “Exchange Cap”), except that such limitation shall not apply
in the event that the Company obtains, at its election, the approval of its stockholders as required by the applicable rules of the Principal Market for issuances of Common Stock in excess of such amount. Until such approval or written opinion is
obtained, no shares of Common Stock shall be issued in the aggregate, upon conversion or exercise or otherwise, as applicable, of the Warrants, in an amount greater than the product of the Exchange Cap multiplied by a fraction, the numerator of
which is the number of Warrants issued to the Holder and the denominator of which is the aggregate number of Warrants issued to all holders of Warrants (with respect to each Holder, the “Exchange Cap Allocation”). In the event that
the Holder shall sell or otherwise transfer this Warrant, the transferee, if a registered holder of such Warrant, shall be allocated a pro rata portion of the Holder’s Exchange Cap Allocation, and the restrictions of the prior sentence shall
apply to such transferee with respect to the portion of the Exchange Cap Allocation allocated to such transferee. In the event that the Holder shall exercise all of the Holder’s Warrants into a number of shares of Common Stock which, in the
aggregate, is less than the Holder’s Exchange Cap Allocation, then the difference between the Holder’s Exchange Cap Allocation and the number of shares of Common Stock actually issued to the Holder shall be allocated to the respective
Exchange Cap Allocations of the remaining registered holders of Warrants on a pro rata basis in proportion to the aggregate number of Warrants then held by each such holder. To the extent required by the Principal Market, the provisions of the
Exchange Cap shall be modified to comply with the applicable rules and regulations of the Principal Market. 

  
 -4-

 Notwithstanding anything in this Warrant to the contrary, the Company shall be entitled to
treat the registered holder of this Warrant as such appears in its records, as the owner of this Warrant for all purposes; provided that such records are kept current using a reasonably satisfactory and customary method intended for such purpose.

 2. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares
shall be adjusted from time to time as follows: 
 (a) Adjustment upon Subdivision or Combination of Common Stock. If the
Company at any time on or after the Issuance Date subdivides (by any forward stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding shares of Common Stock into a
greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Issuance Date
combines (by any reverse stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect
immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 2(a) shall become effective at the close of business on the date the
subdivision or combination becomes effective. 
 (b) De Minimis Adjustments. No adjustment in the Exercise Price shall be
required unless such adjustment would require an increase or decrease of at least $0.01 in such price, provided, however, that any adjustment which by reason of this Section 2(b) is not required to be made shall be carried forward and taken
into account in any subsequent adjustments under this Section 2. All calculations under this Section 2 shall be made by the Company in good faith and shall be made to the nearest cent or to the nearest one hundredth of a share, as
applicable. No adjustment need be made for a change in the par value or no par value of the Company’s Common Stock. 
 3.
RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock generally (which dividend or other distribution
has not already been given to the Holder), by way of return of capital or otherwise not addressed by Section 2 above (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
stock split, spin off, subdivision, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant and prior to the Expiration Date,
then, in each such case: 
 (a) any Exercise Price in effect immediately prior to the close of business on the record date fixed
for the determination of holders of shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price determined by multiplying such Exercise Price by a fraction of
which (i) the numerator shall be the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by the Company’s Board of
Directors) applicable to one share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and 

  
 -5-

 (b) the number of Warrant Shares shall be increased or decreased to a number of shares equal
to the number of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution multiplied by the reciprocal of
the fraction set forth in the immediately preceding paragraph (a); provided that in the event that the Distribution is of shares of Common Stock or common stock of a company whose common shares are traded on a national securities exchange or
a national automated quotation system (“Other Shares of Common Stock”), then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an adjustment in the number of Warrant Shares, the terms of
which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the number of shares of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had the Holder
exercised this Warrant immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the terms of
the immediately preceding paragraph (a) and the number of Warrant Shares calculated in accordance with the first part of this paragraph (b). 
 4. PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS. 
 (a) Purchase Rights.
In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the record holders of
any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) immediately prior to the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. 

(b) In connection with any Fundamental Transaction, the Company shall make appropriate provision so that this Warrant shall thereafter be
exercisable for shares of the Successor Entity based upon the conversion ratio or other consideration payable in the Fundamental Transaction. The provisions of this Section shall apply similarly and equally to successive Fundamental
Transactions and shall be applied without regard to any limitations on the exercise of this Warrant. Without limiting the foregoing, in connection with a Fundamental Transaction that constitutes a Change of Control, at the request of the Holder
delivered before the 90th day after such Fundamental Transaction, the Company (or the Successor Entity) shall purchase this Warrant from the Holder by paying to the Holder, within five (5) Business Days after such request (or, if later, on the
effective date of the Fundamental Transaction), cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of such Fundamental Transaction. 

5. COVENANT TO PERFORM. The Company hereby covenants and agrees that the Company will at all times in good faith carry out all the
provisions of this Warrant and take all 

  
 -6-

 
action that is required hereunder to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of
Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding, take action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock,
solely for the purpose of effecting the exercise of this Warrant, 100% of the number of shares of Common Stock issuable upon exercise of this Warrant then outstanding (without regard to any limitations on exercise). 

6. WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such
Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon
the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock,
reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then
entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a
stockholder of the Company. 
 7. REISSUANCE OF WARRANTS. 

(a) Transfer of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, together
with a written assignment of this Warrant duly executed by the Holder or its agent or attorney, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as
the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in
accordance with Section 7(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred. 
 (b) Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case
of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company reasonably satisfactory to the Company and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and
deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant. 
 (c) Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance
with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is
designated by the Holder at the time of such surrender; provided, however, that no Warrants for fractional shares of Common Stock shall be given. 

  
 -7-

 (d) Issuance of New Warrants. Whenever the Company is required to issue a new Warrant
pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant
(or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in
connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and
(iv) shall have the same rights and conditions as this Warrant. 
 8. NOTICES. The Company shall provide Holder with
prompt written notice of all actions taken pursuant to this Warrant and the reason therefore. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in writing, will be mailed
(a) if within the domestic United States by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered from outside the United States, by
International Federal Express or facsimile, and (c) will be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight
carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic confirmation of receipt, and will be delivered and
addressed as follows: 
 (i) if to the Company, to: 
 1277 Orleans Drive 
 Sunnyvale, CA 94089 

Attention: Patricia Hart 
 Facsimile: (408) 990-4040 
 With a copy to: 

Wilson Sonsini Goodrich & Rosati, Professional Corporation 

650 Page Mill Road 
 Palo Alto 94304 
 Attention: Aaron Alter 

(ii) if to the Holder, at the address of the Holder appearing on the books of the Company. 

9. AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may
take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder. 

  
 -8-

 10. GOVERNING LAW. This Warrant shall be governed by and construed and enforced in
accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. 

11. CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be
construed against any person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant. 

12. DISPUTE RESOLUTION. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of
the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within three (3) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder.
If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the
Holder, then the Company shall, within two (2) Business Days submit via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or
(b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant. The Company shall cause, at the expense of the prevailing party, the investment bank or the accountant, as the case may be, to
perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or
accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. 
 13. REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law
or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant.

 14. TRANSFER. This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

 15. CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 (a) “Black Scholes Value” means the value of this Warrant based on the Black and Scholes Option Pricing
Model obtained from the “OV” function on Bloomberg using (i) a price per share of Common Stock equal to the Weighted Average Price of the Common Stock for the Trading Day immediately preceding the date of consummation of the
applicable Fundamental Transaction, (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction and
(iii) an expected volatility equal to the greater of 70% and the 30 day volatility obtained from the HVT function on Bloomberg determined as of the Trading Day immediately following the public announcement of the applicable Fundamental
Transaction. 

  
 -9-

 (b) “Bloomberg” means Bloomberg Financial Markets. 

(c) “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York or San Jose, California are authorized or required by law to remain closed. 
 (d) “Change of Control”
means any Fundamental Transaction other than (A) any reorganization, recapitalization or reclassification of the Common Stock, in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization or
reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly, the voting power of the surviving entity or entities necessary to elect a majority of the
members of the board of directors (or their equivalent if other than a corporation) of such entity or entities, or (B) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company.

 (e) “Closing Bid Price” and “Closing Sale Price” means, for any security as of any date,
the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing
bid price or the closing trade price, as the case may be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the
principal securities exchange or trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as
reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or,
if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets”
by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale
Price, as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such
dispute shall be resolved pursuant to Section 12. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. 

(f) “Common Stock” means (i) the Company’s shares of Common Stock, par value $0.001 per share, and
(ii) any share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock. 
 (g) “Eligible Market” means the Principal Market, The New York Stock Exchange, Inc., The American Stock Exchange, The NASDAQ Capital Market, The NASDAQ Global Market or The NASDAQ Global
Select Market. 

  
 -10-

 (h) “Expiration Date” means the date sixty (60) months after the
Issuance Date or, if such date falls on a day other than a Business Day or on which trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday. 

(i) “Fundamental Transaction” means that the Company shall, directly or indirectly, in one or more related transactions,
(i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the
Company to another Person, or (iii) allow another Person to make a purchase, tender or exchange offer that is accepted by such number of holders of outstanding shares of Common Stock resulting in such Person (together with any affiliates of
such Person) holding more than 50% of the outstanding Common Stock of the Company following such purchase, tender or exchange offer, or (iv) consummate a stock purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with another Person resulting in such other Person (together with any affiliates of such Person) holding more than the 50% of the outstanding Common Stock of the Company following
such stock purchase agreement or other business combination or (v) reorganize, recapitalize or reclassify its Common Stock. 
 (j) “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or
any department or agency thereof. 
 (k) “Principal Market” means The NASDAQ Global Market. 

(l) “Successor Entity” means the Person formed by, resulting from or surviving any Fundamental Transaction or the Person
with which such Fundamental Transaction shall have been entered into. 
 (m) “Trading Day” means any day on
which the Common Stock are traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock are then
traded; provided that “Trading Day” shall not include any day on which the Common Stock are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock are suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time). 

(n) “Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price for such
security on the Principal Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume at Price” function or, if the
foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at
4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price
of any of the market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National 

  
 -11-

 
Quotation Bureau, Inc.). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date
shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 12 with
the term “Weighted Average Price” being substituted for the term “Exercise Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction during such period.

 [Signature Page Follows] 

  
 -12-

 IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to
be duly executed as of the Issuance Date set out above. 
  

			
	QUICKLOGIC CORPORATION
	
	
By:                       
                                         
                  

	 Name:
	 	
	 Title:
	 	

 Exhibit A 
 EXERCISE NOTICE 
 TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS 
 WARRANT TO PURCHASE COMMON STOCK 
 QUICKLOGIC CORPORATION 
 The undersigned holder hereby exercises the right
to purchase             of the shares of Common Stock (“Warrant Shares”) of Quicklogic Corporation, a Delaware corporation (the “Company”), evidenced by
the attached Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant. 

1. Form of Exercise Price. The Holder’s payment of the Exercise Price shall be made as: 

a “Cash Exercise” with respect to            Warrant Shares;
and/or 
 a “Cashless Exercise” with respect
to            Warrant Shares. 
 2. Payment of Exercise
Price. In the event that the Holder conducted a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $ to the Company in accordance with the
terms of the Warrant. 
 3. Delivery of Warrant Shares. The Company shall deliver to the Holder Warrant Shares in
accordance with the terms of the Warrant. 
 4. Confirmation. Please send confirmation of receipt of this Exercise Notice
to the following facsimile number: 
 Date:            , 

 

			
	
	  
 Name of Registered Holder

		
	 By:
	 	  

		 	 Name:

		 	 Title:

 ACKNOWLEDGMENT 

The Company hereby acknowledges this Exercise Notice and hereby directs American Stock Transfer & Trust Company to issue the
above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated            from the Company and acknowledged and agreed to by American Stock
Transfer & Trust Company. 
  

			
	QUICKLOGIC CORPORATION
		
	 By:
	 	  

		 	 Name:

		 	 Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]